Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur produces a portfolio of high quality vaccines among them a number of vaccines aimed at the prevention of pertussis infection. Every day, the company invests more than EUR 1 million in research and development.
Within the PERISCOPE project, Sanofi Pasteur will be taking the role of EFPIA Coordinator and will contribute in-kind to all work packages. This contribution will include providing scientific, statistical or bioinformatics expertise, conducting laboratory-based research activities and taking responsibility for the co-leadership of some work packages. Sanofi Pasteur will support the overall project management and coordination by acting as a member of the Consortium’s Management Team and Steering Committee. Furthermore, they will prepare and participate in interactions with regulatory agencies and support communication and dissemination activities.
Dr. Patricia Londoño-Hayes, Senior Director of R&D Initiatives, Europe at Sanofi Pasteur will be the appointed EFPIA Coordinator of PERISCOPE. Dr. Londoño-Hayes is a scientific investigator with 18 years of experience in the Discovery, Research and Development of Vaccines. She has expertise on immunology, non-clinical pharmacology and infectious disease, including Pertussis, and has a track record in leading both programs and teams at the scientific/technical, operational and strategic levels in the biotechnology and pharmaceutical sectors.